We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Inhaler Sales Driving Global Respiratory Device Market

By HospiMedica International staff writers
Posted on 30 May 2012
A new study shows the respiratory market reached USD 44.2 billion 2011 as a result of a worldwide increase in respiratory disease and an aging population.

In a recent research report titled World Market for Respiratory Devices, Kalorama Information (Kalorama; Rockville, MD, USA), a medical research publisher, examined the size and growth of the respiratory device market to determine trends in the industry.

Kalorama’s report showed that growth in the market is the result of an increased incidence of Chronic obstructive pulmonary disease (COPD) and a need for home-based care products, according to Bruce Carlson, publisher, Kalorama.

“The bulk of the market growth is expected to arise from an increasing incidence of COPD worldwide and from innovative products entering the market,” said Mr. More...
Carlson. “The market will also grow thanks to the shifting trend towards the use of home care products for the graying population across the globe.”

Respiratory market products include inhalers, nebulizers, sleep apnea equipment, oxygen therapy equipment, medical humidifiers, and respiratory measurement devices. Kalorama’s report also discovered the largest component of the market is respiratory inhalers and therapeutic pharmaceuticals, which account for roughly 77% of the total sales for the industry.

Devices that contain pharmaceuticals administered through an inhaler represent the largest volume of market sales. However, Kalorama notes that the dollar volume of inhalers should not mask the growth opportunities in other device categories.

“The lion’s share of the market is inhalers, but there are other devices that are going to drive revenue growth as well, and we detail these in the report,” added Carlson.

The report indicated that some industry areas will experience growth of 7%-9% over the next five years.

Kalorama Information is a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries.


Related Links:
Kalorama Information


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.